Ondansetron 2 MG/ML Injectable Solution — RxCUI 283504
RxNorm drug concept · Semantic clinical drug
RxCUI 283504
Semantic clinical drug · SCD
● Current RxNorm concept 26 FDA products
29 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI283504
Official nameOndansetron 2 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asondansetron (as ondansetron HCl ) 2 MG/ML Injectable Solution
FDA products mapped26
Package NDCs mapped29
Reported Medicaid activity (SDUD)534,145 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ondansetron: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Not at all. Ondansetron is approved to prevent nausea and vomiting from cancer chemotherapy, radiation therapy to the abdomen or whole body, and surgery. So you might receive it be...
- What exactly is ondansetron used for — is it just for chemo patients?
- The regular tablet is swallowed like any other pill. The orally disintegrating tablet (ODT) is placed on your tongue and allowed to dissolve — don't chew or swallow it whole. For c...
- How do I take the tablet or the dissolving tablet correctly?
🕸️ Concept Web — How Ondansetron 2 MG/ML Injectable Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ondansetron 2 MG/ML Injectable Solution
RxCUI 283504 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ondansetron
26225IN
-
Ondansetron
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ondansetron Injectable Solution
376327SCDF -
Ondansetron Injectable Product
1161031SCDG -
Injectable Solution
316949DF -
Injectable Product
1151126DFG
-
Ondansetron Injectable Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ondansetron 2 MG/ML
328448SCDC
-
Ondansetron 2 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ondansetron 2 MG/ML
SCDC · 328448 -
Ondansetron Injectable Solution
SCDF · 376327 -
Ondansetron Injectable Product
SCDG · 1161031
📦 FDA Products & Package NDCs
26 products · 29 package NDCs
29 package NDCs map to RxCUI 283504 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9890-01 | 20 mL in 1 VIAL, MULTI-DOSE (0143-9890-01) | Ondansetron | West-Ward Pharmaceuticals Corp | 2006-12-26 |
| 00143-9890-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (0143-9890-10) / 20 mL in 1... | Ondansetron | West-Ward Pharmaceuticals Corp | 2006-12-26 |
| 00143-9891-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-9891-25) / 2 mL in 1... | Ondansetron | West-Ward Pharmaceuticals Corp | 2006-12-26 |
| 00409-4755-03 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4755-03) / 2 mL in 1 V... | Ondansetron | Hospira, Inc. | 2008-10-16 |
| 00409-4759-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-4759-01) / 20 mL in 1... | Ondansetron | Hospira, Inc. | 2006-11-07 |
| 00641-6078-25 | 25 VIAL in 1 CARTON (0641-6078-25) / 2 mL in 1 VIAL (0641-6... | Ondansetron | Hikma Pharmaceuticals USA Inc. | 2006-12-26 |
| 00641-6079-01 | 20 mL in 1 CARTON (0641-6079-01) | Ondansetron | Hikma Pharmaceuticals USA Inc. | 2006-12-26 |
| 00641-6080-25 | 25 VIAL in 1 CARTON (0641-6080-25) / 2 mL in 1 VIAL (0641-6... | Ondansetron | Hikma Pharmaceuticals USA Inc. | 2006-12-26 |
| 00641-6286-01 | 20 mL in 1 VIAL, MULTI-DOSE (0641-6286-01) | Ondansetron | Hikma Pharmaceuticals USA Inc. | 2006-12-26 |
| 16729-0298-05 | 20 mL in 1 VIAL (16729-298-05) | ondansetron | Accord Healthcare, Inc. | 2016-10-20 |
| 23155-0547-41 | 10 VIAL in 1 CARTON (23155-547-41) / 2 mL in 1 VIAL (23155-... | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2012-06-15 |
| 23155-0547-42 | 25 VIAL in 1 CARTON (23155-547-42) / 2 mL in 1 VIAL (23155-... | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2012-06-15 |
| 23155-0548-41 | 10 VIAL in 1 CARTON (23155-548-41) / 2 mL in 1 VIAL (23155-... | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-11-09 |
| 23155-0548-42 | 25 VIAL in 1 CARTON (23155-548-42) / 2 mL in 1 VIAL (23155-... | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-11-09 |
| 23155-0549-31 | 1 VIAL in 1 CARTON (23155-549-31) / 20 mL in 1 VIAL | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2012-06-15 |
| 23155-0550-31 | 1 VIAL in 1 CARTON (23155-550-31) / 20 mL in 1 VIAL | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-11-09 |
| 36000-0012-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (36000-012-25) / 2 mL in 1... | ONDANSETRON HYDROCHLORIDE | Baxter Healthcare Corporation | 2013-03-13 |
| 51662-1377-01 | 20 mL in 1 VIAL (51662-1377-1) | ONDANSETRON | HF Acquisition Co LLC, DBA HealthFirst | 2020-05-21 |
| 55150-0125-02 | 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-125-02) / 2 mL in 1... | Ondansetron | Eugia US LLC | 2012-12-21 |
| 55150-0126-20 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-126-20) / 20 mL in 1... | Ondansetron | Eugia US LLC | 2012-12-21 |
| 63323-0373-02 | 25 VIAL in 1 TRAY (63323-373-02) / 2 mL in 1 VIAL (63323-37... | Ondansetron | Fresenius Kabi USA, LLC | 2009-11-18 |
| 63323-0374-20 | 1 VIAL in 1 BOX (63323-374-20) / 20 mL in 1 VIAL | Ondansetron | Fresenius Kabi USA, LLC | 2009-11-18 |
| 68083-0114-01 | 1 VIAL in 1 CARTON (68083-114-01) / 20 mL in 1 VIAL | Ondansetron | Gland Pharma Limited | 2012-06-15 |
| 71872-7107-01 | 1 VIAL, MULTI-DOSE in 1 BAG (71872-7107-1) / 20 mL in 1 VIA... | Ondansetron | Medical Purchasing Solutions, LLC | 2018-05-30 |
| 72266-0123-25 | 25 VIAL in 1 CARTON (72266-123-25) / 2 mL in 1 VIAL (72266-... | Ondansetron | Fosun Pharma USA Inc. | 2019-04-02 |
| 72266-0124-01 | 1 VIAL in 1 CARTON (72266-124-01) / 20 mL in 1 VIAL | Ondansetron | Fosun Pharma USA Inc. | 2019-04-02 |
| 83270-0161-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (83270-161-01) / 20 mL in 1... | ondansetron hydrochloride | Onesource Specialty Pharma Limited | 2023-09-30 |
| 85766-0199-20 | 1 VIAL, MULTI-DOSE in 1 CARTON (85766-199-20) / 20 mL in 1... | Ondansetron | Sportpharm LLC | 2026-04-14 |
| 86211-0115-01 | 1 VIAL in 1 CARTON (86211-115-01) / 20 mL in 1 VIAL | Ondansetron | JVET PHARMACEUTICALS LLC | 2026-03-23 |
Observed labelers:
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (6) ·
Hikma Pharmaceuticals USA Inc. (4) ·
West-Ward Pharmaceuticals Corp (3) ·
Eugia US LLC (2) ·
Fosun Pharma USA Inc. (2) ·
Fresenius Kabi USA, LLC (2)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2405 | Ondansetron hcl injection | 17 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.